Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.
Douglas A. Nemecek, MD
Advertisement
Articles by Douglas A. Nemecek, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
2
ADA 2026: Lipid Management and Cardiovascular Prevention Updates for People With Diabetes
3
McKesson ideaShare 2026: Why Automation and AI Are Reshaping the Dispensing Experience
4
World Psychedelics Day: Why Pharmacy Can't Sit This One Out
5